Menu

Breaking News

HRSA Approves 340B Rebate Proposals for Nine Drugs Under Pilot Program, Expands Data Requirements

William Newton, Associate Editor/Senior Writer 340B Report Views
HRSA on Oct. 30 announced that it had approved eight drugs for its 340B rebate pilot program.
The Health Resources and Services Administration (HRSA) on Thursday approved 340B rebate models for nine drugs under its controversial 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

House Lawmakers in Talks to Launch Bipartisan 340B Working Group as Counterpart to Senate ‘Gang of Six’

Novartis Says it Plans to Still Partake in HRSA’s 340B Rebate Pilot; Providers, Drug Industry Diverge on Approvals 

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

340B Report Categories

More Categories

Recent Articles

Article Archives